The DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.
Bladder tumor markers beyond cytology: International Consensus Panel on bladder tumor markers
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
RETRACTED: Highly specific urine-based marker of bladder cancer
Le, T.-S. V., Miller, R., Barder, T. J., Babjuk, M. M., Potter, D. M., & Getzenberg, R. H. (2005) · Urology · doi:10.1016/j.urology.2005.07.010 · Cited by 63
Self-citationRetractedFunctional Characterization of the Bladder Cancer Marker, BLCA-4
Le, T.-S. V., Myers, J., Konety, B. R., Barder, T. J., & Getzenberg, R. H. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-0455-03 · Cited by 63
Self-citationRetractedSpecific Association of Human Telomerase Activity with Immortal Cells and Cancer
Kim, N. W., Piatyszek, M. A., Prowse, K. R., Harley, C. B., West, M. D., Ho, P. L. C., Coviello, G. M., Wright, W. E., Weinrich, S. L., & Shay, J. W. (1994) · Science · doi:10.1126/science.7605428 · Cited by 7,091
Abundant class of human DNA polymorphisms which can be typed using the polymerase chain reaction.
Weber, J. L., & May, P. E. (1989) · Europe PMC (PubMed Central) · Cited by 3,399
Meyerson, M., Counter, C. M., Eaton, E. N., Ellisen, L. W., Steiner, P., Caddle, S. D., Ziaugra, L., Beijersbergen, R. L., Davidoff, M. J., Liu, Q., et al. (1997) · Cell · doi:10.1016/s0092-8674(00)80538-3 · Cited by 1,784
Phases of Biomarker Development for Early Detection of Cancer
Pepe, M. S., Etzioni, R., Feng, Z., Potter, J. D., Thompson, M. L., Thornquist, M., Winget, M., & Yasui, Y. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.14.1054 · Cited by 1,686
Dangers of Using "Optimal" Cutpoints in the Evaluation of Prognostic Factors
Altman, D. G., Lausen, B., Sauerbrei, W., & Schumacher, M. (1994) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/86.11.829 · Cited by 1,143
Identification of a nuclear protein matrix
Berezney, R., & Coffey, D. S. (1974) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(74)90355-6 · Cited by 996
Survivin, versatile modulation of cell division and apoptosis in cancer
Altieri, D. C. (2003) · Oncogene · doi:10.1038/sj.onc.1207113 · Cited by 900
The health economics of bladder cancer: A comprehensive review of the published literature
Botteman, M. F., Pashos, C. L., Redaelli, A., Laskin, B., & Hauser, R. (2003) · PharmacoEconomics · doi:10.1007/bf03262330 · Cited by 860
A fixed site of DNA replication in eucaryotic cells
Pardoll, D. M., Vogelstein, B., & Coffey, D. S. (1980) · Cell · doi:10.1016/0092-8674(80)90527-9 · Cited by 655
Microsatellite alterations in plasma DNA of small cell lung cancer patients
Qi Chen, X., Stroun, M., Magnenat, J.-L., Nicod, L. P., Kurt, A.-M., Lyautey, J., Lederrey, C., & Anker, P. (1996) · Nature Medicine · doi:10.1038/nm0996-1033 · Cited by 647
Statistical aspects of prognostic factor studies in oncology
Simon, R., & Altman, D. (1994) · British Journal of Cancer · doi:10.1038/bjc.1994.192 · Cited by 582
Hyaluronan: a multifunctional, megaDalton, stealth molecule
Lee, J. Y., & Spicer, A. P. (2000) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(00)00135-6 · Cited by 525
Ulaner, G. A., Hu, J., Vu, T. H., Giudice, L. C., & Hoffman, A. R. (1998) · PubMed · Cited by 495
Lotan, Y., & Roehrborn, C. G. (2003) · Urology · doi:10.1016/s0090-4295(02)02136-2 · Cited by 474
Molecular Detection of Primary Bladder Cancer by Microsatellite Analysis
Mao, L., Schoenberg, M. P., Scicchitano, M., Erozan, Y. S., Merlo, A., Schwab, D., & Sidransky, D. (1996) · Science · doi:10.1126/science.271.5249.659 · Cited by 376
Detection of Bladder Cancer Using a Point-of-Care Proteomic Assay
Grossman, H. B. (2005) · JAMA · doi:10.1001/jama.293.7.810 · Cited by 367
Self-citationCOMPARISON OF SCREENING METHODS IN THE DETECTION OF BLADDER CANCER
RAMAKUMAR, S., BHUIYAN, J., BESSE, J. A., ROBERTS, S. G., WOLLAN, P. C., BLUTE, M. L., & O'KANE, D. J. (1999) · Journal of Urology · doi:10.1016/s0022-5347(01)61899-8 · Cited by 335
Soloway, M. S., Briggman, J. V., Carpinito, G. A., Chodak, G. W., CHURCH, P. A., Lamm, D. L., Lange, P. H., Messing, E. M., Pasciak, R. M., Reservitz, G. B., et al. (1996) · The Journal of Urology · doi:10.1016/s0022-5347(01)65851-8 · Cited by 331
Self-citationLokeshwar, V. B., Rubinowicz, D., Schroeder, G. L., Forgacs, E., Minna, J. D., Block, N. L., Nadji, M., & Lokeshwar, B. L. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008432200 · Cited by 303
Self-citationSokolova, I. A., Halling, K. C., Jenkins, R. B., Burkhardt, H. M., Meyer, R. G., Seelig, S. A., & King, W. (2000) · The Journal of Molecular Diagnostics · doi:10.1016/s1525-1578(10)60625-3 · Cited by 285
Detection of bladder cancer recurrence by microsatellite analysis of urine
Steiner, G., Schoenberg, M. P., Linn, J. F., Mao, L., & Sidransky, D. (1997) · Nature Medicine · doi:10.1038/nm0697-621 · Cited by 277
Zeegers, M. P. A., Kellen, E., Buntinx, F., & van den Brandt, P. A. (2004) · World Journal of Urology · doi:10.1007/s00345-003-0382-8 · Cited by 272
Tumor Markers in the Diagnosis of Primary Bladder Cancer. A Systematic Review
GLAS, A. S., ROOS, D., DEUTEKOM, M., ZWINDERMAN, A. H., BOSSUYT, P. M. M., & KURTH, K. H. (2003) · Journal of Urology · doi:10.1097/01.ju.0000067461.30468.6d · Cited by 268
Case-Control Study of Bladder Cancer and Drinking Water Arsenic in the Western United States
Steinmaus, C. (2003) · American Journal of Epidemiology · doi:10.1093/aje/kwg281 · Cited by 260
Diagnostic value of cytology of voided urine.
Koss, L. G., Deitch, D., Ramanathan, R., & Sherman, A. B. (1985) · PubMed · Cited by 247
Sensitivity and specificity of NMP-22, telomerase, and BTA in the detection of human bladder cancer
Landman, J., Chang, Y., Kavaler, E., Droller, M. J., & Liu, B. C.-S. (1998) · Urology · doi:10.1016/s0090-4295(98)00219-2 · Cited by 239
Self-citationGenetic alterations in bladder cancer
Dalbagni, G., Presti, J., Fair, W. R., Reuter, V., & Cordon-Cardo, C. (1993) · The Lancet · doi:10.1016/0140-6736(93)91595-d · Cited by 238
NuMA: an unusually long coiled-coil related protein in the mammalian nucleus.
Yang, C. H., Lambie, E. J., & Snyder, M. (1992) · The Journal of cell biology · doi:10.1083/jcb.116.6.1303 · Cited by 224
LOKESHWAR, V. B., ÖBEK, C., PHAM, H. T., WEI, D., YOUNG, M. J., DUNCAN, R. C., SOLOWAY, M. S., & BLOCK, N. L. (2000) · Journal of Urology · doi:10.1016/s0022-5347(05)68050-0 · Cited by 223
Self-citationSHARMA, S., ZIPPE, C. D., PANDRANGI, L., NELSON, D., & AGARWAL, A. (1999) · Journal of Urology · doi:10.1097/00005392-199907000-00014 · Cited by 194
HALLING, K. C., KING, W., SOKOLOVA, I. A., KARNES, R. J., MEYER, R. G., POWELL, E. L., SEBO, T. J., CHEVILLE, J. C., CLAYTON, A. C., KRAJNIK, K. L., et al. (2002) · Journal of Urology · doi:10.1016/s0022-5347(05)65072-0 · Cited by 188
THE NATURAL HISTORY OF BLADDER CANCER
Lee, R. E., Jr., & Droller, M. J. (2000) · Urologic Clinics of North America · doi:10.1016/s0094-0143(05)70229-9 · Cited by 183
Self-citationSouthgate, J., Harnden, P., & Trejdosiewicz, L. K. (1999) · PubMed · doi:10.14670/hh-14.657 · Cited by 174
Gazzaniga, P., Gradilone, A., Giuliani, L., Gandini, O., Silvestri, I., Nofroni, I., Saccani, G., Frati, L., & Aglianò, A. M. (2003) · Annals of Oncology · doi:10.1093/annonc/mdg002 · Cited by 173
West, D. C., & Kumar, S. (2007) · Novartis Foundation Symposia · doi:10.1002/9780470513774.ch12 · Cited by 170
URINE BASED MARKERS OF UROLOGICAL MALIGNANCY
Konety, B. R., & Getzenberg, R. H. (2001) · The Journal of Urology · doi:10.1097/00005392-200102000-00081 · Cited by 150
Self-citationDetection of Telomerase Activity in Exfoliated Cells in Urine From Patients With Bladder Cancer
Kinoshita, H., Ogawa, O., Kakehi, Y., Mishina, M., Itoh, N., Yamada, H., Terachi, T., & Yoshida, O. (1997) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/89.10.724 · Cited by 141
Complement factor H or a related protein is a marker for transitional cell cancer of the bladder.
Kinders, R. J., Jones, T., Root, R., Bruce, C. L., Murchison, H. A., Corey, M. J., Williams, L., Enfield, D. L., & Hass, G. M. (1998) · PubMed · Cited by 127
A study comparing various noninvasive methods of detecting bladder cancer in urine
Saad, A., Hanbury, D. C., McNicholas, T., Boustead, G. B., Morgan, S., & Woodman, A. (2002) · British Journal of Urology · doi:10.1046/j.1464-4096.2001.01699.x · Cited by 117
Lokeshwar, V. B., Schroeder, G. L., Selzer, M. G., HAUTMANN, S. H., Posey, J., DUNCAN, R. C., Watson, R. B., Rose, L., Markowitz, S. B., & Soloway, M. S. (2002) · Cancer · doi:10.1002/cncr.10652 · Cited by 116
Self-citationLotan, Y., & Roehrborn, C. G. (2002) · The Journal of Urology · doi:10.1016/s0022-5347(05)65386-4 · Cited by 110
Aromatic Amines and Human Urinary Bladder Cancer: Exposure Sources and Epidemiology
Talaska, G. (2003) · Journal of Environmental Science and Health Part C · doi:10.1081/gnc-120021372 · Cited by 104
Life and Cancer Without Telomerase
Zakian, V. A. (1997) · Cell · doi:10.1016/s0092-8674(01)80001-5 · Cited by 99
HAUTMANN, S. H., Toma, M. I., Gómez, M. F., Friedrich, M. G., Jäkel, T., Michl, U. H. G., Schroeder, G. L., Huland, H., Juenemann, K., & Lokeshwar, V. B. (2004) · European Urology · doi:10.1016/j.eururo.2004.06.006 · Cited by 94
Self-citationIdentification of bladder tumor-derived hyaluronidase: its similarity to HYAL1.
Lokeshwar, V. B., Young, M. J., Goudarzi, G., Iida, N., Yudin, A. I., Cherr, G. N., & Selzer, M. G. (1999) · PubMed · Cited by 94
Self-citationThe Health Economics of Bladder Cancer
Botteman, M. F., Pashos, C. L., Redaelli, A. C. L., et al. (2003) · PharmacoEconomics · doi:10.2165/00019053-200321180-00003 · Cited by 89
van Rhijn, B. W. G., Lurkin, I., Chopin, D. K., Kirkels, W. J., Thiery, J. P., van der Kwast, T., Radvanyi, F., & Zwarthoff, E. C. (2003) · PubMed · Cited by 86
Giannopoulos, A., MANOUSAKAS, T., GOUNARI, A., et al. (2001) · The Journal of Urology · doi:10.1016/s0022-5347(05)65965-4 · Cited by 85
Biomarker Risk Assessment and Bladder Cancer Detection in a Cohort Exposed to Benzidine
Hemstreet, G. P., Yin, S., Ma, Z., Bonner, R. B., Bi, W., Rao, J., Zang, M., Zheng, Q., Bane, B. L., Asal, N. R., et al. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.6.427 · Cited by 78
Self-citationFriedrich, M. G., Toma, M. I., Hellstern, A., Pantel, K., Weisenberger, D. J., Noldus, J., & Huland, H. (2003) · British Journal of Urology · doi:10.1111/j.1464-410x.2003.04528.x · Cited by 77
Telomerase: a potential marker of bladder transitional cell carcinoma in bladder washes.
Lee, D. H., Yang, S. C., Hong, S. J., Chung, B. H., & Kim, I. Y. (1998) · PubMed · Cited by 64
Dalbagni, G. M., Han, W., Zhang, Z., Cordon‐Cardo, C., Saigo, P. E., Fair, W. R., Herr, H. W., Kim, N., & Moore, M. A. S. (1997) · PubMed · Cited by 60
Schultz, I. J., Kiemeney, L. A. L. M., Witjes, J. A., Schalken, J. A., Willems, J. L., Swinkels, D. W., & de Kok, J. B. (2003) · PubMed · Cited by 57
Self-citationHoque, M. O., Lee, J., Begum, S., Yamashita, K., Engles, J. M., Schoenberg, M., Westra, W. H., & Sidransky, D. (2003) · PubMed · Cited by 57
Usefulness of the BTA stat Test for the diagnosis of bladder cancer
Baños, J. L. G., Rodrigo, M. D. H. R., Juárez, F. M. A., & García, B. M. (2001) · Urology · doi:10.1016/s0090-4295(00)01090-6 · Cited by 52
Parekattil, S. J., Fisher, H. A. �., & Kogan, B. A. (2003) · The Journal of Urology · doi:10.1097/01.ju.0000051322.60266.06 · Cited by 45
Bialkowska-Hobrzanska, H., Bowles, L., Bukala, B., Joseph, M. G., Fletcher, R., & RAZVI, H. A. (2000) · PubMed · doi:10.1007/bf03262087 · Cited by 31
Prognostic factors: guidelines for investigation design and state of the art analytical methods
Drew, P. J., Ilstrup, D. M., Kerin, M. J., & Monson, J. R. T. (1998) · Surgical Oncology · doi:10.1016/s0960-7404(98)00029-2 · Cited by 18
Wu, X., Kakehi, Y., Takahashi, T., Habuchi, T., & Ogawa, O. (2000) · International Journal of Urology · doi:10.1046/j.1442-2042.2000.00178.x · Cited by 16
Self-citationWhat do we mean by validating a prognostic model?
(2000) · doi:10.1002/(sici)1097-0258(20000229)19:4<453::aid-sim350>3.0.co;2-5
Cited by
EAU Guidelines on Non–Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016
Babjuk, M., Böhle, A., Burger, M., Capoun, O., Cohen, D., Compérat, E. M., Hernández, V., Kaasinen, E., Palou, J., Rouprêt, M., et al. (2017) · European Urology · doi:10.1016/j.eururo.2016.05.041 · Cited by 2,241
Breast Cancer, Version 4.2017, NCCN Clinical Practice Guidelines in Oncology
Gradishar, W. J., Anderson, B. O., Balassanian, R., Blair, S. L., Burstein, H. J., Cyr, A., Elias, A. D., Farrar, W. B., Forero, A., Giordano, S. H., et al. (2018) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2018.0012 · Cited by 1,609
EAU Guidelines on Non–Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2013
Babjuk, M., Burger, M., Zigeuner, R., Shariat, S. F., van Rhijn, B. W. G., Compérat, E., Sylvester, R. J., Kaasinen, E., Böhle, A., Palou Redorta, J., et al. (2013) · European Urology · doi:10.1016/j.eururo.2013.06.003 · Cited by 1,174
EAU Guidelines on Non–Muscle-Invasive Urothelial Carcinoma of the Bladder, the 2011 Update
Babjuk, M., Oosterlinck, W., Sylvester, R., Kaasinen, E., Böhle, A., Palou-Redorta, J., & Rouprêt, M. (2011) · European Urology · doi:10.1016/j.eururo.2011.03.017 · Cited by 1,067
EAU Guidelines on Non-Muscle-Invasive Urothelial Carcinoma of the Bladder
Babjuk, M., Oosterlinck, W., Sylvester, R., Kaasinen, E., Böhle, A., & Palou-Redorta, J. (2008) · European Urology · doi:10.1016/j.eururo.2008.04.051 · Cited by 723
Metadata
- Authors
- Lokeshwar, V. B., Habuchi, T., Grossman, H. B., Murphy, W. M., Hautmann, S. H., Hemstreet, G. P., Bono, A. V., Getzenberg, R. H., Goebell, P., Schmitz-Dräger, B. J., Schalken, J. A., Fradet, Y., Marberger, M., Messing, E., & Droller, M. J.
- Venue
- Urology
- Publisher
- Elsevier BV
- Published
- 2005-12
- Volume
- 66
- Issue
- 6
- Pages
- 35-63
- ISSN
- 0090-4295 (ISSN-L)
- OpenAlex
- W2128580887
- Cited by
- 431
- References
- 62
- FWCI
- 19.41
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.